65,437 trials
Thalamus
Primary: Change in Sensitivity Derived From the Signal Detection Theory (SDT) — 0.7452; 0.7419; 0.7520; 0.7120 units on a scale — p=0.02
Sickle Cell Disease
Primary: Proportion of Biochemically Old Red Cell Units — 0.71; 0.86 proportion biologically old units — p=0.051
Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia
Primary: Overall Survival — 47 percentage of participants
Depressive Symptoms · Depression
Primary: Mean Score of Depressive Symptoms — -5.95; -11.24; -10.69 score on a scale
Respiratory Rate
Primary: Test of the Difference Between airRR and mancRR — 0.422; 14.362; 14.784 breaths per minute — p=<0.001
Acute Ischemic Stroke
Primary: 90-day Utility Weighted Modified Rankin Scores (UW-mRS) — 5.2; 6.3; 6.8 score on a scale — p=0.002
Prostatic Neoplasms
Primary: Confirmed Biochemical Recurrence (BCR)-Free Rate at Month 24 — 100 Percentage of participants
Gastroenteritis Norovirus
Primary: The Occurrence of Norovirus-associated Illness in Secretor Positive Participants Through Day 4 After Challenge. — 3; 2; 7; 0 Participants
Early Alzheimer's Disease
Primary: Mean Percent Change in Apolipoprotein A-I (ApoA-I) in Cerebrospinal Fluid (CSF) — -8.4 percent change from screening visit — p=0.425
Renal Cell Carcinoma · Urinary Bladder Neoplasms
Primary: Objective Response Rate (Percentage of Patients With Complete Response or Partial Response) — 7.7; 0; 16.7 percentage of participants
Elective Surgical Procedures
Primary: Patient Knowledge — 32.2; 53 score on a scale
Functional Gastrointestinal Disorders
Primary: Rumination Score (Self-perceived Rumination Frequency) — 4 score on a scale — p=0.005
Substance Abuse
Primary: Indicators of Feasibility — 6; 6; 5; 5 Coded interview segments
Gingival Recession
Primary: KT Width at 6 Month Following Grafting With VISTA and Sulcular Tunnel Access With ADM — 3.15; 2.23 mm
Physical Disability
Primary: In-Home Occupational Performance Evaluation (I-HOPE) Activity Score — 0.73; 0.72; 0.76; 0.69 score on a scale — p=0.068